HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase II multi-center trial single arm trial of autologous transplantation (ASCT)
followed by administration of HST-NEETs for treatment of HIV associated lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
Catherine Bollard
Collaborators:
Blood and Marrow Transplant Clinical Trials Network Children's National Research Institute National Cancer Institute (NCI) National Heart, Lung, and Blood Institute (NHLBI) National Marrow Donor Program